There are 2789 resources available
336TiP - Ipatasertib plus non-taxane chemotherapy for metastatic triple-negative breast cancer (TNBC): Pathfinder trial
Presenter: Antonio Llombart Cussac
Session: ePoster Display
337TiP - An open-label, phase Ib/II study to evaluate the safety and efficacy of fruquintinib in combination with tislelizumab in patients with advanced triple-negative breast cancer
Presenter: Debu Tripathy
Session: ePoster Display
338TiP - CAPItello-292: A phase 1b/3 study of capivasertib, palbociclib and fulvestrant versus placebo, palbociclib and fulvestrant in HR+/HER2− advanced breast cancer
Presenter: Erika Hamilton
Session: ePoster Display
339TiP - SOLTI-1502 ARIANNA: Targeting PAM50 HER2-enriched intrinsic subtype with enzalutamide in hormone receptor-positive/HER2-negative metastatic breast cancer
Presenter: Luis Manso
Session: ePoster Display
348P - Up-regulation of sorcin promotes glioblastoma progression via activating the PI3K/AKT/mTOR pathway
Presenter: Zhangya Pu
Session: ePoster Display
349P - The amount of cancer stem cells and the sensitivity to anticancer drugs in glioblastoma primary cell culture
Presenter: Olga Susova
Session: ePoster Display
365P - The analysis of FGFR-gene family alterations in glioma
Presenter: yunqian Li
Session: ePoster Display
366P - The genetic landscape of tumor predisposition syndromes in Chinese patients with glioma
Presenter: Rutong Yu
Session: ePoster Display
367P - The analysis of STAG2 variants in Chinese adult patients with glioma
Presenter: yongli bo
Session: ePoster Display
368P - Characteristics of deleterious germline mutations in glioma patients
Presenter: Gousiyi Wang
Session: ePoster Display